A recent study shows that serum #Midkine suppresses #OsteoblastDifferentiation via the #PI3K-AKT pathway and increases #Inflammatory #Cytokines via the #NFκB pathway, promising a therapeutic target for postmenopausal #Osteoporosis. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...